Yenikomshian, MBA, M.A., White, PhD, A.G., Carson, BS, M.E., Garrison, PhD, L.P., Oderda, PharmD, MPH, G.M., Biskupiak, PhD, MBA, J.E., Hlavacek, MPH, P.R. and Roland, PharmD, MS, C.L. 2017. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients. Journal of Opioid Management. 13, 5 (Sep. 2017), 291–301. DOI:https://doi.org/10.5055/jom.2017.0398.